<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557579</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT04557579</nct_id>
  </id_info>
  <brief_title>Comparison of Quality of Vision After Bifocal and Extended Depth of Focus Intraocular Lens Implantation</brief_title>
  <official_title>Comparison of Quality of Vision After Bifocal and Extended Depth of Focus Intraocular Lens Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Nobel Eye Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Nobel Eye Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the visual performance of the extended depth of focus (EDOF) intraocular lens&#xD;
      (IOL) to bifocal and spherical monofocal IOL&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was conducted from 2018 to 2020. This study included patients who were with&#xD;
      presence of cataract in both eyes, age between 50 and 80 years, and corrected distance visual&#xD;
      acuity (CDVA) of both eyes under 20/40. Phacoemulsification cataract surgery was arranged for&#xD;
      both eyes for all patients. The study groups of IOL models include EDOF Symfony IOL (AMO,&#xD;
      Santa Ana, CA, USA), bifocal Restor +2.5D IOL (Alcon, Fort Worth, TX, USA), and monofocal&#xD;
      Sensar AR40e IOL (AMO, Santa Ana, CA, USA). The patients were routinely examined&#xD;
      preoperatively as well as 1 month after surgery for far and near visual acuity (in LogMAR&#xD;
      unit). Contrast sensitivity, wavefront aberration and quality of vision questionnaire was&#xD;
      measured at the 1-month postoperative visit. These aforementioned outcomes were recorded and&#xD;
      compared between groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 24, 2018</start_date>
  <completion_date type="Actual">January 22, 2020</completion_date>
  <primary_completion_date type="Actual">January 22, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ophthalmic examinations</measure>
    <time_frame>1 month after surgery.</time_frame>
    <description>far uncorrected visual acuity(UCVA) and corrected distance visual acuity (CDVA), near UCVA in LogMAR unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wavefront examination</measure>
    <time_frame>at the 1-month postoperative visit</time_frame>
    <description>Wavefront analysis was performed only at the 1-month postoperative visit with an AMO WaveScan Hartmann-Shack sensor (Santa Clara, CA, USA). The wavefront maps were analyzed using a 6-mm pupil diameter and a Zernike polynomial expansion up to the sixth-order of Zernike coefficients. Higher order aberrations including RMS errors of horizontal coma aberration (Z 3,1), spherical aberration (4,0), trefoil aberration and the higher order aberrations were assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>at the 1-month postoperative visit</time_frame>
    <description>CS was also measured at the 1-month postoperative visit using the Vector Vision CSV-1000 (Greenville, OH, USA) chart. All subjects were tested at the recommended distance of 8 feet. The CSV-1000 consists of a series of circular achromatic sine-wave patches having a 1.5-in. diameter and comprising 4 rows, each corresponding to one of 4 spatial frequencies: 3, 6, 12, and 18 cycles per degree (cpd). We selected 3, 6 and 12 cpd for analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire</measure>
    <time_frame>at the 1-month postoperative visit</time_frame>
    <description>Subjective QoV was evaluated using a questionnaire adopted from a near-activity 19-item questionnaire and the NEI-RQL-42. Our questionnaire contains 11 questions and the subscales include far vision, diurnal fluctuation, glare and halos, spectacle dependence, near vision, and intermediate vision. In general, questionnaires were completed without assistance; however, on the patient's request, explanations of the questions were provided.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">97</enrollment>
  <condition>Intraocular Lens</condition>
  <arm_group>
    <arm_group_label>Bifocal group</arm_group_label>
    <description>Patients in bifocal group implanted with Restor +2.5D IOL (Alcon, Fort Worth, TX, USA) in bilateral eyes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extended depth of focus group</arm_group_label>
    <description>Patients in extended depth of focus group implanted with EDOF Symfony IOL (AMO, Santa Ana, CA, USA) in bilateral eyes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monofocal group</arm_group_label>
    <description>Patients in monofocal group implanted with Sensar AR40e IOL (AMO, Santa Ana, CA, USA) in bilateral eyes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Clear corneal phacoemulsification and IOL implantation</intervention_name>
    <description>Clear corneal phacoemulsification and IOL implantation were performed by 2 surgeons (Chao-Kai Chang and Hung-Yuan Lin) by using an identical technique to minimize differences in surgically induced aberrations between groups. The surgical process involved topical anesthesia, a 3-step clear corneal incision (2.75 mm) at 180° (temporal in both eyes), a 5.0-mm continuous curvilinear capsulorhexis, phacoemulsification using the stop-and-chop technique, IOL implantation with an injector, IOL centration, and a sutureless incision. The study IOL models include EDOF Symfony IOL (AMO, Santa Ana, CA, USA), bifocal Restor +2.5D IOL (Alcon, Fort Worth, TX, USA), and monofocal Sensar AR40e IOL (AMO, Santa Ana, CA, USA).</description>
    <arm_group_label>Bifocal group</arm_group_label>
    <arm_group_label>Extended depth of focus group</arm_group_label>
    <arm_group_label>Monofocal group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study was conducted from 2018 to 2020 in the Taipei Nobel Eye Clinic and Universal Eye&#xD;
        Center ophthalmology clinic. The research protocol was explained to all prospective&#xD;
        participants, after which they provided written informed consent before participating. The&#xD;
        study was approved by the Ethics Committee of Chunghua Christian Hospital, and the protocol&#xD;
        accorded with the tenets of the Declaration of Helsinki.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  presence of cataract in both eyes&#xD;
&#xD;
          -  age between 50 and 80 years&#xD;
&#xD;
          -  CDVA of both eyes under 20/40&#xD;
&#xD;
          -  Phacoemulsification cataract surgery was arranged for both eyes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  complicated cataract&#xD;
&#xD;
          -  corneal opacities or irregularities&#xD;
&#xD;
          -  corneal astigmatism &gt; 1.5 diopter&#xD;
&#xD;
          -  dry eye (Schirmer's test I ≤ 5mm)&#xD;
&#xD;
          -  amblyopia&#xD;
&#xD;
          -  anisometropia&#xD;
&#xD;
          -  surgical complications such as posterior capsular bag rupture or vitreous loss&#xD;
&#xD;
          -  IOL tilt or decentration&#xD;
&#xD;
          -  coexisting ocular pathologies&#xD;
&#xD;
          -  glaucoma&#xD;
&#xD;
          -  non-dilating pupil&#xD;
&#xD;
          -  history of intraocular surgery, laser therapy, or retinopathy&#xD;
&#xD;
          -  optic nerve or macular diseases&#xD;
&#xD;
          -  refusal or unable to maintain follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chao-Kai Chang, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Nobel Eye Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Taipei Nobel Eye Clinic</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Calladine D, Evans JR, Shah S, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD003169. doi: 10.1002/14651858.CD003169.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 12;12 :CD003169.</citation>
    <PMID>22972061</PMID>
  </reference>
  <reference>
    <citation>Kohnen T, Nuijts R, Levy P, Haefliger E, Alfonso JF. Visual function after bilateral implantation of apodized diffractive aspheric multifocal intraocular lenses with a +3.0 D addition. J Cataract Refract Surg. 2009 Dec;35(12):2062-9. doi: 10.1016/j.jcrs.2009.08.013.</citation>
    <PMID>19969209</PMID>
  </reference>
  <reference>
    <citation>Thibos LN, Ye M, Zhang X, Bradley A. The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humans. Appl Opt. 1992 Jul 1;31(19):3594-600. doi: 10.1364/AO.31.003594.</citation>
    <PMID>20725330</PMID>
  </reference>
  <reference>
    <citation>Pérez-Merino P, Dorronsoro C, Llorente L, Durán S, Jiménez-Alfaro I, Marcos S. In vivo chromatic aberration in eyes implanted with intraocular lenses. Invest Ophthalmol Vis Sci. 2013 Apr 12;54(4):2654-61. doi: 10.1167/iovs.13-11912.</citation>
    <PMID>23493299</PMID>
  </reference>
  <reference>
    <citation>Weeber HA, Piers PA. Theoretical performance of intraocular lenses correcting both spherical and chromatic aberration. J Refract Surg. 2012 Jan;28(1):48-52. doi: 10.3928/1081597X-20111103-01. Epub 2011 Nov 10.</citation>
    <PMID>22074466</PMID>
  </reference>
  <reference>
    <citation>Denoyer A, Le Lez ML, Majzoub S, Pisella PJ. Quality of vision after cataract surgery after Tecnis Z9000 intraocular lens implantation: effect of contrast sensitivity and wavefront aberration improvements on the quality of daily vision. J Cataract Refract Surg. 2007 Feb;33(2):210-6.</citation>
    <PMID>17276260</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 27, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Nobel Eye Clinic</investigator_affiliation>
    <investigator_full_name>Chao-Kai Chang</investigator_full_name>
    <investigator_title>Dean, Nobel Eye Institute</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

